carbostyril has been researched along with Adenocystic Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dillon, PM; Douvas, MG; Fracasso, PM; Horton, BJ; Moskaluk, CA; Petroni, GR; Thomas, CY; Varhegyi, N; Zaja-Milatovic, S | 1 |
| Bang, YJ; Cho, BC; Keam, B; Kim, MK; Kim, SB; Lee, KW; Lee, SH; Shin, SH; Yoon, DH; Yun, HJ | 1 |
2 trial(s) available for carbostyril and Adenocystic Carcinoma
| Article | Year |
|---|---|
A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.
Topics: Adult; Aged; Benzimidazoles; Carcinoma, Adenoid Cystic; Cell Proliferation; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oncogene Proteins v-myb; Quinolones; Receptor, Fibroblast Growth Factor, Type 1 | 2017 |
Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzimidazoles; Carcinoma, Adenoid Cystic; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Quinolones; Republic of Korea; Salivary Gland Neoplasms; Treatment Outcome; Young Adult | 2015 |